(Q48941494)

17 February 2018

title

IL-4Rα aptamer-liposome-CpG oligodeoxynucleotides suppress tumour growth by targeting the tumour microenvironment (English)

1 reference

17 February 2018

author name string

Yu-Jie Liu

1

1 reference

17 February 2018

Xiao-Qian Dou

2

1 reference

17 February 2018

Fang Wang

3

1 reference

17 February 2018

Jing Zhang

4

1 reference

17 February 2018

Xiao-Lin Wang

5

1 reference

17 February 2018

Gui-Li Xu

6

1 reference

17 February 2018

Shen-Si Xiang

7

1 reference

17 February 2018

Xin Gao

8

1 reference

17 February 2018

Jie Fu

9

1 reference

17 February 2018

Hai-Feng Song

10

1 reference

17 February 2018

publication date

7 November 2016

1 reference

17 February 2018

Journal of Drug Targeting

published in

1 reference

17 February 2018

volume

25

1 reference

17 February 2018

issue

3

1 reference

17 February 2018

page(s)

275-283

1 reference

17 February 2018

T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Thioredoxin induces Tregs to generate an immunotolerant tumor microenvironment in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Myeloid-derived suppressor cells as effectors of immune suppression in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Nanoparticles evading the reticuloendothelial system: role of the supported bilayer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Structure-efficacy relationships of immunostimulatory activity of CpG-containing oligodeoxynucleotides on mouse spleen cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Immunostimulatory and anti-neoplasm effects of a novel palindrome CpG oligodeoxynucleotide in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

The RNA-binding protein RBPMS1 represses AP-1 signaling and regulates breast cancer cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Myeloid-derived suppressor cells in cancer: recent progress and prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Modulators of arginine metabolism do not impact on peripheral T-cell tolerance and disease progression in a model of spontaneous prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1061186X.2016.1258569

10.1080/1061186X.2016.1258569

21 January 2018

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018